Meeting
2015 Gastrointestinal Cancers Symposium
Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysis.
Authors
Anna Dorothea Wagner
Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland
Anna Dorothea Wagner , Markus Moehler , Wilfried Grothe , Johannes Haerting , Susanne Unverzagt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 125)
DOI
10.1200/jco.2015.33.3_suppl.125
Abstract #
125
Poster Bd #
C23
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2020 Gastrointestinal Cancers Symposium
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first‑line therapy in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.
First Author: Rui-hua Xu
Poster
2015 Gastrointestinal Cancers Symposium
Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.
First Author: Sebastian Ochenduszko
Poster
2014 ASCO Annual Meeting
Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.
First Author: Bertrand Brieau